🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Pine Labs posts Rs 42 Cr profit in Q3 FY26; revenue grows 24%

EntrackrEntrackr · 1d ago
Pine Labs posts Rs 42 Cr profit in Q3 FY26; revenue grows 24%
Medial

Fintech major Pine Labs announced its financial results for Q3 FY26 after debuting on Indian stock exchanges in the same quarter. The firm’s revenue increased by 24% during the third quarter, while it remained profitable in the same period. The company’s revenue from operations increased to Rs 744 crore in Q3 FY26 from Rs 601 crore in the same quarter last year, according to its financial statement sourced from NSE. Other income contributed an additional Rs 36 crore, which drove its total income to Rs 780 crore for the quarter. For the nine-month period ending December 2025, the firm’s revenue increased 20% to Rs 2,010 crore from Rs 1,676 crore, a year earlier. On the expense side, employee benefit was the largest cost centre, which accounted for 37% of the total expense. This cost increased by 5% to Rs 263 crore in Q3 FY26 from Rs 251 crore in Q3 FY25. Cost of material rose 51% to Rs 104 crore in Q3 FY26 from Rs 69 crore in Q3 FY25. Finance cost and depreciation cost were other overheads which led to the total expense to increase by 13% to Rs 705 crore in Q3 FY26. Pine Labs entered profitability on the back of steady growth and disciplined cost control, reporting a net profit of Rs 42 crore in Q3 FY26 versus a loss of Rs 57 crore in Q3 FY25. For the nine-month period, the company posted a profit of Rs 53 crore. Pine Labs made a positive debut on the public markets, listing at a 9.5% premium over its issue price. The stock opened at Rs 242 per share against the IPO price of Rs 221, giving the Peak XV-backed firm a stable start on the NSE and BSE. Earlier this month, Pine Labs received RBI approval to fully acquire RBI-licensed account aggregator Agya Technologies, increasing its stake to 100% from its previous associate company status. The company’s share is trading at Rs 233, giving it a market capitalization of Rs 26,736 crore (approximately $2.9 billion).

Pine Labs India posts Rs 1,384 Cr revenue in FY24; losses jump 3X

EntrackrEntrackr · 1y ago
Pine Labs India posts Rs 1,384 Cr revenue in FY24; losses jump 3X
Medial

The Indian unit of merchant commerce and payments platform Pine Labs has reported flat revenue in the fiscal year ending March 2024. However, the Delhi-based firm’s losses swelled 3X in this period. Pine Labs’s operating revenue increased modestly by 2.8% to Rs 1,317 crore in FY24 from Rs 1,281 crore in FY23, its annual financial statements sourced from the Registrar of Companies show. Caveat: Pine Labs is registered in Singapore and has not yet submitted its FY24 results there. Based on the previous fiscal year’s report, the parent entity is expected to post approximately Rs 400 crore more or over Rs 1,700 crore in operating revenue in the last fiscal year. As for the revenue channels of Pine Labs’ Indian entity, income from transaction processing and settlement was the main contributor, accounting for 61% of total operating revenue, which rose a modest 1.5% to Rs 805 crore in FY24. Income from digitization and services provided at petroleum outlets amounted to Rs 67 crore during the same period. Pine Labs also offers gifting solutions through Qwikcilver, Pine Perks, and Google Wallet. Income from this segment declined by 44.5% to Rs 111 crore in FY24. Revenue from device sales, plastic cards, and other miscellaneous sources brought the total revenue to Rs 1,384 crore during the last fiscal year, compared to Rs 1,328 crore in FY23. In terms of cost breakdown, Pine Labs allocated 38.5% of its total expenditure to employee benefits, which grew by 3% to Rs 625 crore in FY24, including Rs 58 crore in non-cash ESOP expenses. Legal and professional fees were the next largest expense category. Other significant costs included materials, travel, advertising, e-commerce site listings, database communication, and repairs, bringing total expenditures up by 15.8% to Rs 1,624 crore in FY24. FY23-FY24 FY23 FY24 EBITDA Margin 14.91% 10.55% Expense/₹ of Op Revenue ₹1.09 ₹1.23 ROCE -1.65% -7.87% The modest growth in scale, combined with a nearly 16% rise in expenditure, led Pine Labs to report a more than threefold increase in losses, reaching Rs 187 crore in FY24 compared to Rs 56 crore in FY23. Its ROCE and EBITDA margin stood at -7.87% and 10.55%, respectively. On a per-unit basis, Pine Labs spent Rs 1.23 to earn a rupee in FY24. Pine Labs recently received approval from a Singapore court to relocate its domicile to India. It also obtained initial approval from the National Company Law Tribunal to merge its entities in India and Singapore. Pine Labs has been pursuing an initial public offering (IPO) for several years. Last year, the company appointed bankers for a U.S. IPO, but the attempt did not materialize. While the firm has not yet confirmed a listing timeline, it is likely to debut on one of the Indian stock exchanges sometime in the next fiscal year (FY26).

PB Fintech posts Rs 1,348 Cr revenue in Q1 FY26; profit increases 42%

EntrackrEntrackr · 6m ago
PB Fintech posts Rs 1,348 Cr revenue in Q1 FY26; profit increases 42%
Medial

PB Fintech posts Rs 1,348 Cr revenue in Q1 FY26; profit increases 42% PB Fintech, the parent company of online insurance aggregator and brokerage platform PolicyBazaar, has released its financial results for the first quarter of the ongoing fiscal year (Q1 FY26). The company reported a 33% growth in scale, while its year-on-year (YoY) profits increased by 42% during the same period. PolicyBazaar’s revenue from operations surged 33% to Rs 1,348 crore in Q1 FY26 in contrast to Rs 1,011 crore in Q1 FY25, as per the firm’s financial results sourced from the National Stock Exchange (NSE). The Gurugram-based company generated the largest share (88%) of its operating revenue from insurance broker services, which rose to Rs 1,187 crore in Q1 FY26 from Rs 845 crore in Q1 FY25. Besides operating revenue, the firm also earned Rs 99 crore via interest and gains from financial assets during the quarter which took its total topline to Rs 1,447 crore in the quarter ending June 2025. PolicyBazaar has not provided a detailed breakdown of expenses in its quarterly financial statements. However, employee benefits expenses rose by 23% YoY to Rs 560 crore. Overall, the company's total costs grew 25% to Rs 1,356 crore in Q1 FY26 compared to Rs 1,081 crore in Q1 FY25. PolicyBazaar's net profits surged 42% to Rs 85 crore in Q1 FY26 from Rs 60 crore in Q1 FY25. At the end of the day, PolicyBazaar traded at Rs 1,808 with a total market capitalization of Rs 83,033 crore (approximately $9.5 billion).

Pine Labs-owned Setu to acquire 100% stake in Agya Technologies

EntrackrEntrackr · 9d ago
Pine Labs-owned Setu to acquire 100% stake in Agya Technologies
Medial

Pine Labs-owned Setu to acquire 100% stake in Agya Technologies Fintech unicorn Pine Labs plans to fully consolidate its ownership in RBI-licensed account aggregator Agya Technologies through its fintech infrastructure arm, Setu. According to a regulatory filing, the RBI has approved Setu (BrokenTusk Technologies Pvt Ltd) to increase its stake to 100% in Agya Technologies Pvt Ltd, which until now has operated as an associate company of Setu. Pine Labs already has around 25% stake in Agya Technologies and the company plans to complete the acquisition of the remaining stake in the near term, potentially in one or more tranches, according to the filing. This development follows Pine Labs' successful acquisition of all three digital payment licences from the Reserve Bank of India (RBI). These licences cover offline payments, online merchant payments, and cross-border transactions, enabling the company to offer a complete range of digital payment services across all merchant interaction points. On the financial front, Pine Labs’ revenue increased to Rs 650 crore in Q2 FY26 from Rs 551 crore in the same quarter last year. Pine Labs reported a net profit of Rs 6 crore in Q2 FY26 versus a loss of Rs 32 crore in Q2 FY25. Pine Labs made a positive debut on the public markets, listing at a 9.5% premium over its issue price. The stock opened at Rs 242 per share against the IPO price of Rs 221, giving the Peak XV-backed firm a stable start on the NSE and BSE. The company’s share is trading at Rs 240.85, giving it a market capitalization of Rs 26,406 crore (approx $2.9 billion).

Thyrocare posts Rs 216 Cr revenue in Q2 FY26; profit rises 81%

EntrackrEntrackr · 3m ago
Thyrocare posts Rs 216 Cr revenue in Q2 FY26; profit rises 81%
Medial

Thyrocare posts Rs 216 Cr revenue in Q2 FY26; profit rises 81% Diagnostics major Thyrocare Technologies posted a strong performance in the second quarter of FY26, reporting strong growth in both revenue and profit, supported by higher testing volumes across its diagnostic and imaging segments. The company’s consolidated revenue from operations grew 22% year-on-year (YoY) to Rs 216.5 crore in Q2 FY26 from Rs 177.36 crore in Q2 FY25, as per its filings with the stock exchanges. Sequentially, the company’s revenue rose 12% from Rs 193 crore in Q1 FY26. The growth was primarily driven by the diagnostic testing services segment, which contributed over 93% of total revenue, while the imaging services segment (including PET-CT and radiopharmaceuticals) accounted for Rs 14.2 crore during the quarter. Thyrocare’s profit after tax jumped 81% YoY to Rs 47.9 crore in Q2 FY26, compared to Rs 26.4 crore in the corresponding quarter last year, aided by margin expansion and operational leverage. For the first half of FY26, the company recorded a net profit that grew 71% to Rs 86.1 crore from Rs 50.4 crore in H1 FY25. The company’s EBITDA margin improved to 33%, with total expenses growing at a slower pace (10% YoY) than revenue. During the quarter, the cost of materials consumed rose to Rs 59.8 crore, while employee benefits expenses stood at Rs 33.2 crore. Thyrocare’s board has also approved a 2:1 bonus issue, allotting two fully paid-up shares for every existing share held by shareholders as of the record date. The board also declared an interim dividend of Rs 7 per share for FY26, with October 24 set as the record date. At the end of H1FY26, Thyrocare had a total current asset of Rs 323 crore with cash and bank balances of Rs 70 crore. The company is currently traded at Rs 1270.5 (as on 12.35 PM) with the total market capitalization of Rs 6,754 crore ($767 million).

Pine Labs rewards CEO Amrish Rau with Rs 243 Cr ESOPs ahead of market debut

EntrackrEntrackr · 2m ago
Pine Labs rewards CEO Amrish Rau with Rs 243 Cr ESOPs ahead of market debut
Medial

url: https://entrackr.com/news/pine-labs-rewards-ceo-amrish-rau-with-rs-243-cr-esops-ahead-of-market-debut-10617990. Content: Pine Labs has filed its RHP for a Rs 3,900 crore IPO. In the past four months, it added ESOPs worth Rs 564.75 crore, including Rs 243 crore granted to CEO Amrish Rau. Merchant payments and lending platform Pine Labs has filed its RHP for a Rs 3,900 crore IPO. In the past four months, the company added ESOPs worth Rs 564.75 crore, with a large portion valued at Rs 243 crore granted to their Chief Executive Officer, Amrish Rau. According to its RHP, Pine Labs had an ESOP pool of 6.15 crore options valued at Rs 1,360 crore as of June 30, 2025. Over the following four months (July 1 to November 1), the company granted an additional 2.55 crore options, expanding the total pool to 8.7 crore. Of these, 2.75 crore options were exercised and converted into equity shares at exercise prices ranging from Rs 5.4 to Rs 156. Some options were forfeited or lapsed during the period, leaving Pine Labs with 5.89 crore as a total outstanding ESOP options valued at around Rs 1,300 crore ($148 million). Of the 2.55 crore options granted in the past four months, 1.1 crore were allotted to CEO Amrish Rau, with the remainder going to other key managerial personnel. According to the red herring prospectus, before June 2025, Rau had already had 2.31 crore options, bringing his total to 3.41 crore worth Rs 755.6 crore. Pine Labs’ Rs 3,900 crore IPO includes a fresh issue of equity shares worth Rs 2,080 crore and an offer for sale (OFS) of up to 8.23 crore shares valued at Rs 1,820 crore by existing shareholders. In the OFS, early backer Peak XV is set to receive around Rs 508.4 crore, earning a return of nearly 40x on its investment. Other shareholders, including Madison India, Sofina Ventures, Temasek, PayPal, Mastercard, Invesco, and Lone Cascade, will also participate in the share sale. Pine Labs recorded a 28.5% year-on-year rise in revenue to Rs 2,274 crore in FY25, up from Rs 1,769 crore in FY24, while its net loss narrowed by 57% to Rs 145 crore. Notably, the company turned profitable in the first quarter of FY26, reporting a net profit of Rs 4.7 crore on revenue of Rs 616 crore.

Pine Labs delivers back-to-back profitable quarters

EntrackrEntrackr · 1m ago
Pine Labs delivers back-to-back profitable quarters
Medial

Pine Labs announced its financial results for Q2 FY26 after debuting on Indian stock exchanges earlier last month. The firm’s revenue increased by 18% during the second quarter, while the firm remained profitable in the same period. The company’s revenue from operations increased to Rs 650 crore in Q2 FY26 from Rs 551 crore in the same quarter last year, according to its financial statement sourced from NSE. Other income contributed an additional Rs 23 crore, which drove its total income of Rs 673 crore for the quarter. However, for the six-month period ending September 2025, the firm’s revenue increased 18% to Rs 1,266 crore in H1 FY26 from Rs 1,074 crore in H1 FY25. On the expense side, employee benefit was the largest cost centre, which accounted for 40% of the total expense. This cost increased by 4% to Rs 268 crore in Q2 FY26 from Rs 258 crore in Q2 FY25. Cost of material rose 4% to Rs 81 crore in Q2 FY26 from Rs 78 crore in Q2 FY25. Finance cost, depreciation cost were other overheads which led to the total expense increasing by 8% to Rs 662 crore in Q2 FY26. Pine Labs sustained its profitability on the back of steady growth and disciplined cost control, reporting a net profit of Rs 6 crore in Q2 FY26 versus a loss of Rs 32 crore in Q2 FY25. For the half-year period, the company posted a profit of Rs 11 crore in H1 FY26, a marked improvement from the Rs 60 crore loss recorded in H1 FY25. The company also secured three key licences from the RBI, for payment aggregation, payment gateway operations, and cross-border payments, covering both offline and online merchant transactions. These approvals allow Pine Labs to process domestic and international payments, manage settlements, and further expand its merchant network across sectors. The IPO, which closed on November 11, raised around Rs 3,900 crore, comprising a mix of fresh issuance and an offer for sale by existing shareholders. While institutional investors drove the bulk of the demand, retail participation remained modest. Pine Labs made a positive debut on the public markets, listing at a 9.5% premium over its issue price. The stock opened at Rs 242 per share against the IPO price of Rs 221, giving the Peak XV-backed firm a stable start on the NSE and BSE. At the end of today’s trading period, the company’s share traded at Rs 247, giving it a market capitalization of Rs 28,360 crore (approx $3 billion).

Download the medial app to read full posts, comements and news.